- Shelf Life3 Years
- Supply TypeExporter, Supplier, Retailer, Distributor, Importer, Trader, Buying House
- Preferred Buyer Location All over the world
Clinical efficacy. Kaplan-Meier survival analysis revealed a median PFS of 10.7 months and OS of 21.2 months. The response rates observed were as follows: CR 5.6 %, PR 50 %, SD 16.7 %, and PD 27.8 %. The overall response rate (ORR) was 55.6 % and the disease control rate (DCR) was 72.2 %. Etoposide (also known as VP-16) is used in combination with other cancer medicines to treat small cell lung cancer. Etoposide belongs to the group of medicines known as antineoplastic agents.